MedPath

A clinical trial of ATTATHI CHOORANAM in the management of RAKTHA SOORAI VAAYU (POLY CYSTIC OVARIAN SYNDROME)

Phase 2
Not yet recruiting
Conditions
Polycystic ovarian syndrome,
Registration Number
CTRI/2019/05/019119
Lead Sponsor
Government Siddha Medical College and Hospital
Brief Summary

The study is a prospective open labelled, non-randomised, phase II clinical trial to determine the efficacy and safety of ATTATHI CHOORANAM in patients with RAKTHA SOORAI VAAYU ( POLY CYSTIC OVARIAN SYNDROME). The trial drug is processed from raw herbs and mineral. In this clinical trial to be held at GSMC, Palayamkottai, 40 patients (20 in OPD + 20 in IPD) will be recruited and the trial drug will be administered at the dose of 40 mg/ Kg/ BW TDS A/F along with Honey or ghee as adjuvant for a period of 48 days. All the study related data will be recorded and documented in a separate file for each patients. In case of any adverse event (AE) is noticed and it will be referred to pharmacovigilance department of SCRI. Further management of patient will be given in OPD, GSMC, Palayamkottai. During this trial all the efficacy and safety parameters will be recorded in the CRF. After completion of trial all the study related data will be analysed statistically.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Marital Status : Married / Unmarried II.
  • Symptoms -Irregular menstruation, oligomenorrhoea (or) amenorrhoea (or) dysmenorrhoea (or) dysfunctional uterine bleeding -Hirsuitism and obesity III.
  • Patient willing to take USG pelvis IV.
  • Patient willing to undergo routine blood investigation V.
  • USG pelvis showing polycystic ovaries VI.
  • Patient willing to participate in trial and signing in consent form.
Exclusion Criteria
  • History of recent hormone therapy (within one year) II.
  • Lactating mother.
  • History of renal disease V.
  • History of Liver diseas VI.
  • Uterine anomalies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnosis of RAKTHA SOORAI VAAYU and evaluation of the therapeutic efficacy of Attathi chooranam. It is assessed by the improvement in the score of irregular menstruation (Intermenstrual period & duration of bleeding) before and after treatment.48 days
Secondary Outcome Measures
NameTimeMethod
Changes in the polycystic swellings of the ovaries in USG pelvis and reduction of other symptoms.48 days

Trial Locations

Locations (1)

Goverment Siddha Medical College and Hospital

🇮🇳

Tirunelveli, TAMIL NADU, India

Goverment Siddha Medical College and Hospital
🇮🇳Tirunelveli, TAMIL NADU, India
Rasenthiran Sasvatha
Principal investigator
8883955520
sasrajenthiran@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.